Feifei Sun
- Periodontics top 2%
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 6
-
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 5
-
- Lung Cancer Research Studies 9
- Cancer Immunotherapy and Biomarkers 5
- Otorhinolaryngology top 10%
-
- Neuroblastoma Research and Treatments 27
-
- Lymphoma Diagnosis and Treatment 12
-
- Sarcoma Diagnosis and Treatment 6
- Journals
- Journal of Clinical Oncology (5 papers)Frontiers in Oncology (5 papers)Frontiers in Immunology (4 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Feifei Sun
90 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 108
- Periodontics 140
- Cancer Research 259
- Molecular Biology 513
- Oncology 195
- Otorhinolaryngology 31
Countries citing papers authored by Feifei Sun
This map shows the geographic impact of Feifei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Sun more than expected).
Fields of papers citing papers by Feifei Sun
This network shows the impact of papers produced by Feifei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Sun. The network helps show where Feifei Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Feifei Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 1 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 9 | |
| 14 | 2021 | 10 | |
| 15 | 2020 | 13 | |
| 16 | 2017 | 10 | |
| 17 | 2015 | 17 | |
| 18 | 2014 | 1 | |
| 19 | 2014 | 58 | |
| 20 | 2011 | 48 |
About Feifei Sun
Feifei Sun is a scholar working on Neurology, Cancer Research, Oncology, Pathology and Forensic Medicine and Hematology, having authored 106 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (27 papers), Lymphoma Diagnosis and Treatment (12 papers), Lung Cancer Research Studies (9 papers), Sarcoma Diagnosis and Treatment (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Epigenetics and DNA Methylation (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Periodontics (140 citations), Cancer Research (259 citations), Molecular Biology (513 citations), Oncology (195 citations) and Otorhinolaryngology (31 citations). Feifei Sun has collaborated with scholars based in China, United States and France. Frequent co-authors include Xun Hu, Xuedong Zhou, Chunyan Dai, Jia Zhu, Junting Huang, Suying Lü, Zijun Zhen, Zonghui Ding, Yizhuo Zhang and Ju-Jun Xie. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Frontiers in Immunology, Cell Death and Disease and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.